about
Clinical immunologic approaches for the treatment of Alzheimer's diseasePrevention of Alzheimer's diseaseCNS immune privilege: hiding in plain sight.Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosisSignaling effect of amyloid-beta(42) on the processing of AbetaPPFilamentous bacteriophage fd as an antigen delivery system in vaccinationChronic intranasal treatment with an anti-Aβ(30-42) scFv antibody ameliorates amyloid pathology in a transgenic mouse model of Alzheimer's diseaseMolecular basis for passive immunotherapy of Alzheimer's diseaseStabilization of a -hairpin in monomeric Alzheimer's amyloid- peptide inhibits amyloid formationThe NALP3 inflammasome is involved in the innate immune response to amyloid-betaSterile inflammation: sensing and reacting to damageNeuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's diseaseDrug delivery to the brain by focused ultrasound induced blood-brain barrier disruption: quantitative evaluation of enhanced permeability of cerebral vasculature using two-photon microscopy.Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Abeta protofibrils.Successful adjuvant-free vaccination of BALB/c mice with mutated amyloid beta peptides.Antibodies targeted to the brain with image-guided focused ultrasound reduces amyloid-beta plaque load in the TgCRND8 mouse model of Alzheimer's diseaseNanowire array chips for molecular typing of rare trafficking leukocytes with application to neurodegenerative pathology.Comparison of two analytical platforms for CSF biomarkers of Alzheimer's diseaseAlum and squalene-oil-in-water emulsion enhance the titer and avidity of anti-Aβ antibodies induced by multimeric protein antigen (1-11)E2, preserving the Igg1-skewed isotype distributionAlzheimer's disease: is a vaccine possible?WNT5A signaling contributes to Aβ-induced neuroinflammation and neurotoxicity.CNS expression of anti-inflammatory cytokine interleukin-4 attenuates Alzheimer's disease-like pathogenesis in APP+PS1 bigenic miceMicroglia in Alzheimer's diseaseConstruction of human Fab library and screening of a single-domain antibody of amyloid-beta 42 oligomers.Complementing the inflammasome.Midkine as a factor to counteract the deposition of amyloid β-peptide plaques: in vitro analysis and examination in knockout mice.Immunomodulation for prion and prion-related diseases.An MRI rating scale for amyloid-related imaging abnormalities with edema or effusion.Intravenous immunglobulin binds beta amyloid and modifies its aggregation, neurotoxicity and microglial phagocytosis in vitro.CXCL1 contributes to β-amyloid-induced transendothelial migration of monocytes in Alzheimer's disease.Toll-like receptor signaling in neural plasticity and disease.A dual vaccine against influenza & Alzheimer's disease failed to enhance anti-β-amyloid antibody responses in mice with pre-existing virus specific memory.Electrostatically Stabilized Magnetic Nanoparticles - An Optimized Protocol to Label Murine T Cells for in vivo MRIPerioperative cognitive decline in the aging population.A truncated and dimeric format of an Affibody library on bacteria enables FACS-mediated isolation of amyloid-beta aggregation inhibitors with subnanomolar affinity.MHC class I limits hippocampal synapse density by inhibiting neuronal insulin receptor signalingLiposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice.Could immunomodulation be used to prevent prion diseases?Current perspectives on cardiac amyloidosis.Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer's disease pathology
P2860
Q22241380-69CB31B5-95E2-472D-B56D-121FD05FE7F6Q22248031-12AE9576-C9F0-4FFA-9891-E418AF9AF0B3Q24642697-FB7012F9-D465-476E-A8F1-4FC54B4A8B71Q24650147-2D384668-AC83-4F35-86EB-BCCFC29803D8Q24656147-32FED3BA-BB91-4434-B13C-A8054B4D60A7Q26864071-5C74321F-C127-48E5-A071-6A37E3B61D70Q27349010-1F846B2A-02C6-4C53-9BB1-9A1EA4904DF3Q27648521-D5A6E442-9DE0-440E-BA1C-6D67FF25E1BEQ27650192-9418A5FD-408D-4BD7-8DB8-735E26B308B8Q29615595-3937FA1F-5AD5-4096-95BA-F1AE7D8BAE30Q29620014-001B3E2A-6177-4B21-A12C-50B81816DECAQ30054419-E54A69C9-972C-4B1D-8DB0-FD0109AFC45CQ30424484-BB40C3D7-BB73-4DC0-98E6-634F4604A4D4Q33307478-43ECB997-0085-4445-B35B-CA6ECB3F13F9Q33320228-FF1D8B2A-453A-41EB-8875-85FBF38D4812Q33582089-19F7E51C-FB17-43CF-9A5C-607C5954487EQ33723262-C00B2BB8-0553-41E3-B7BD-AF43A1598D61Q33757426-19E25997-0396-4E03-B995-EF7D92D11A43Q33831036-CD9934BA-8404-4540-8DDF-C1A822842CC1Q33861011-F3835CC5-FEBF-42F6-B7B5-69BF1F4FC12FQ33999052-4587EDE5-4502-49FB-9E08-FA6769E8BF75Q34017180-D26031DD-5A5C-4DE5-A0C9-EF65FEEA071FQ34114020-3D6F733F-90F2-450D-AB08-05150061C22EQ34153591-075E6A72-27F6-4896-8032-57BA768FF0A6Q34501875-E004DB28-7D02-4ABA-BE70-F0F49F88C2DBQ34506576-86650B7C-5A10-490D-BA8E-954D67307073Q34565644-59140398-401F-48C2-9FD6-C077D188F695Q34597563-D765822A-07B7-406C-9FF7-F7584F13BC84Q34733689-BEEED657-1636-4932-BE2C-41000A7123CFQ34965558-6511EA44-07B1-4074-ABFA-3D8C8452FD19Q34984865-A451B87E-9B2A-4447-A166-6DFFC0F25FE5Q35040016-DED2303F-10C0-4699-91A7-BCE64D5BF124Q35619419-05D5D028-11EC-4DAB-A59D-D675F7378995Q35671802-8F6253D9-E7F4-49D8-B430-D258FD82B561Q35694115-069DB0F8-7C8C-4AD1-A345-AB0A923FBBBBQ35744568-4F91403B-77F6-46D9-B92D-DE3D9268B35BQ35834451-627E172D-A6D3-41E0-AF0D-DBEAAEDE7598Q35875915-46C35CD8-2473-4DBD-87F2-EC5E6E933E77Q35964900-97C8D6F2-73B5-43E9-99CE-0127A715ADB9Q36018333-3F23BB1B-6FA7-42F0-8CD1-5EE7772A1611
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Immunology and immunotherapy of Alzheimer's disease.
@ast
Immunology and immunotherapy of Alzheimer's disease.
@en
type
label
Immunology and immunotherapy of Alzheimer's disease.
@ast
Immunology and immunotherapy of Alzheimer's disease.
@en
prefLabel
Immunology and immunotherapy of Alzheimer's disease.
@ast
Immunology and immunotherapy of Alzheimer's disease.
@en
P356
P1476
Immunology and immunotherapy of Alzheimer's disease.
@en
P2093
Dan Frenkel
P304
P356
10.1038/NRI1843
P577
2006-05-01T00:00:00Z